Literature DB >> 12430097

The role of comprehensive renal clinic in chronic kidney disease stabilization and management: The Northwestern experience.

Cybele Ghossein1, Andres Serrano, Meena Rammohan, Daniel Batlle.   

Abstract

In this article, we maintain that the management of patients with chronic kidney disease (CKD) is best provided in a clinic setting that integrates nephrologic expertise, patient education, and comprehensive supportive services. Our experience with a CKD clinic in an urban academic setting is described. As a way to assess and quantify the impact of our clinic on clinical outcomes, we have analyzed our results in terms of 2 variables: presence of permanent access at the time of dialysis initiation and impact on renal function as assessed by calculated glomerular filtration rate (GFR). The number of clinic visits was taken as an index of comprehensive renal care before dialysis initiation. Individuals who started dialysis with a functioning permanent access had been seen in our clinic more frequently than those seen less frequently (20 +/- 3.5 and 4.4 +/- 2.1 visits, respectively, P <.005). The impact on renal function was analyzed in a group of 80 unselected patients stratified into 3 stages based on the recently published National Kidney Foundation Disease Outcomes Quality Initiative (K/DOQI) guidelines: stage III (mean GFR 39 +/- 1.5 mL/min, n = 21), stage IV (mean GFR 21 +/- 0.6 mL/min, n = 46), and stage V (mean GFR 12 +/-.76 mL/min, n = 13). Provision of comprehensive renal care in conjunction with anemia management using weekly injections of erythropoietin subcutaneously resulted in stabilization of GFR in patients with stages IV and V over a period of 15 months of follow-up evaluation. In patients with stage III CKD, GFR decreased over the initial period of follow-up evaluation (first few months), and to a lesser extent by the end of follow-up evaluation (15 mo). Further studies are underway to discern the factor(s) underlying the overall clinic effect versus a beneficial effect of anemia correction on GFR. Our data suggests that stabilization of GFR is a goal that can be accomplished with comprehensive renal care provided in an organized clinic setting. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 12430097     DOI: 10.1053/snep.2002.35970

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  7 in total

1.  Multidisciplinary team care may slow the rate of decline in renal function.

Authors:  Elizabeth A Bayliss; Bharati Bhardwaja; Colleen Ross; Arne Beck; Diane M Lanese
Journal:  Clin J Am Soc Nephrol       Date:  2011-01-27       Impact factor: 8.237

Review 2.  Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.

Authors:  Emaad M Abdel-Rahman; Lawand Saadulla; W Brian Reeves; Alaa S Awad
Journal:  J Gen Intern Med       Date:  2011-10-18       Impact factor: 5.128

3.  Management of Diabetic Nephropathy in the Elderly: Special Considerations.

Authors:  Emaad M Abdel-Rahman; Tarek Alhamad; W Brian Reeves; Alaa S Awad
Journal:  J Nephrol Ther       Date:  2012-10

4.  Effectiveness of a multidisciplinary clinic in managing children with chronic kidney disease.

Authors:  Shina Menon; Rudolph P Valentini; Gaurav Kapur; Sandra Layfield; Tej K Mattoo
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-28       Impact factor: 8.237

5.  Characterizing pre-dialysis care in the era of eGFR reporting: a cohort study.

Authors:  Khaled Abdel-Kader; Gary S Fischer; James R Johnston; Chen Gu; Charity G Moore; Mark L Unruh
Journal:  BMC Nephrol       Date:  2011-03-15       Impact factor: 2.388

6.  Barriers to successful care for chronic kidney disease.

Authors:  Oliver Lenz; Durga P Mekala; Daniel V Patel; Alessia Fornoni; David Metz; David Roth
Journal:  BMC Nephrol       Date:  2005-10-27       Impact factor: 2.388

7.  Chronic kidney disease care delivered by US family medicine and internal medicine trainees: results from an online survey.

Authors:  Oliver Lenz; Alessia Fornoni
Journal:  BMC Med       Date:  2006-12-12       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.